Sign up to save your podcasts
Or
Share What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Perspectives on 2023 Updates From San Antonio
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Perspectives on 2023 Updates From San Antonio
Join the experts for recent updates on estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6 inhibitors. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999406?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Join the experts for recent updates on estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6 inhibitors. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999406?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
134 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
315 Listeners
Diabetes Core Update
106 Listeners
This Week in Cardiology
868 Listeners
Core EM - Emergency Medicine Podcast
249 Listeners
JAMA Clinical Reviews
498 Listeners
AFP: American Family Physician Podcast
689 Listeners
One-on-One with Eric Topol
18 Listeners
Mayo Clinic Talks
279 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Core IM | Internal Medicine Podcast
1,107 Listeners
Annals On Call Podcast
197 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
24 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
The Curious Clinicians
368 Listeners